This inventor holds 5 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignees: Korea Institute of Science and Technology, Daegu-Gyeongbuk Medical Innovation Foundation, Industry-University Cooperation Foundation Hanyang University. Active years: 2018-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
5 out of 2,250 
1 out of 10 
1 out of 1,245 
Years Active: 2018-2026
Title: Innovations by Han na Cho: Advancements in Protein Kinase Inhibitors
Introduction
Han na Cho is an accomplished inventor based in Seoul, South Korea. His pioneering work focuses on pharmaceutical compositions that hold significant promise in the field of medicinal chemistry. With one patent to his name, Cho has made notable contributions, particularly in the area of protein kinase inhibitors.
Latest Patents
Han na Cho's recent patent is centered around urea compounds that feature a 3,4-dihydropyrimido[4,5-D]pyrimidin-2(1H)-one skeleton. This invention is particularly important as it introduces a pharmaceutical composition that includes a urea compound with protein kinase inhibitory activity. This innovative approach offers new avenues for therapeutic interventions by potentially paving the way for effective treatments in various diseases linked to protein kinases.
Career Highlights
Han na Cho is currently affiliated with the Korea Institute of Science and Technology, where he leverages his expertise to advance research in biochemical and pharmaceutical sciences. His dedication to innovation has positioned him at the forefront of developing compounds that not only enhance our understanding of protein interactions but may also lead to novel therapeutic strategies.
Collaborations
Throughout his career, Han na Cho has worked alongside talented colleagues, including Tae Bo Sim and Woo Young Hur. This collaborative environment fosters innovation and allows for the fusion of ideas, which is crucial for developing new approaches in research and applications in the biotechnology sector.
Conclusion
Han na Cho stands out as a significant figure in the realm of pharmaceutical inventions. His work on urea compounds as protein kinase inhibitors illustrates his commitment to scientific progress and the potential for groundbreaking developments in medicine. As advancements in this field continue, the contributions of inventors like Han na Cho will undoubtedly play a crucial role in shaping the future of healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile